0.00
price down icon100.00%   -0.2071
 
loading

Renalytix Plc Adr Azioni (RNLX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi
Revenues
24.54%
0.535
0.709 0.459
Cost Of Revenue
25.21%
0.601
0.48 0.502
Gross Profit
128.82%
-0.066
0.229 -0.043
Operating Expenses
26.87%
6.487
8.87 8.846
Benefits Costs and Expenses
9.92%
8.278
9.19 10.61
Costs And Expenses
9.92%
8.278
9.19 10.61
Operating Income/Loss
24.16%
-6.553
-8.641 -8.889
Income/Loss From Equity Method Investments
-
- -
Income/Loss From Continuing Operations Before Tax
8.70%
-7.743
-8.481 -10.15
Income Tax Expense/Benefit
100.00%
-
0.004 -
Income/Loss From Continuing Operations After Tax
8.74%
-7.743
-8.485 -10.15
Net Income/Loss
8.74%
-7.743
-8.485 -10.15
Preferred Stock Dividends And Other Adjustments
-
- -
Attributable To Noncontrolling Interest
-
- -
Basic Average Shares
0.40%
97.65
97.27 94.77
Diluted Average Shares
0.40%
97.65
97.27 94.77
Basic Earnings Per Share
11.11%
-0.08
-0.09 -0.11
Diluted Earnings Per Share
11.11%
-0.08
-0.09 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- -
$21.76
price up icon 1.16%
health_information_services WGS
$77.40
price up icon 2.79%
$20.07
price down icon 0.30%
$17.27
price up icon 1.35%
health_information_services TEM
$35.54
price up icon 7.60%
health_information_services WAY
$36.82
price up icon 3.75%
Capitalizzazione:     |  Volume (24 ore):